TAKANASHI KEN — SEC insider filings

SEC reporting owner CIK 1657768. 14 insider filings on record with FilingPulse; latest filed 2026-10-07.

Transaction summary — filings shown

Covers all 14 filings on record, filed 2020-08-20 to 2026-10-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Satsuma Pharmaceuticals, Inc. (STSA)Director, 10% owner41 leg · 22,053,581 sh · $20,068,759—6
Wave Life Sciences, Inc. (WVE)Director10—2 legs · 8,736 sh · $65,85312

Insider filings — TAKANASHI KEN

FiledFormIssuerReported transactionsSource
2026-10-074Wave Life Sciences, Inc. (WVE)Grant/award (A): 10,700 @ $0 · Grant/award (A): 64,000 (derivative) @ $0EDGAR
2026-08-134Wave Life Sciences, Inc. (WVE)Sale (S): 3,864 @ $6.01EDGAR
2026-03-264Wave Life Sciences Ltd. (WVE)Conversion (C): 3,901,348 @ $0 · Conversion (C): 3,901,348 (derivative) @ $0EDGAR
2025-08-134Wave Life Sciences Ltd. (WVE)Grant/award (A): 12,700 @ $0 · Grant/award (A): 76,200 (derivative) @ $0EDGAR
2025-08-074Wave Life Sciences Ltd. (WVE)Sale (S): 4,872 @ $8.75EDGAR
2024-08-144Wave Life Sciences Ltd. (WVE)Grant/award (A): 16,115 @ $0 · Grant/award (A): 32,230 (derivative) @ $0EDGAR
2023-08-094Wave Life Sciences Ltd. (WVE)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2023-06-084Satsuma Pharmaceuticals, Inc. (STSA)Purchase (P): 22,053,581 @ $0.91 · Disposition to issuer (D): 10,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0EDGAR
2022-12-094/ASatsuma Pharmaceuticals, Inc. (STSA)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2022-08-174Wave Life Sciences Ltd. (WVE)Grant/award (A): 21,000 (derivative) @ $0EDGAR
2022-06-074Satsuma Pharmaceuticals, Inc. (STSA)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2021-08-184Wave Life Sciences Ltd. (WVE)Grant/award (A): 42,000 (derivative) @ $0EDGAR
2020-12-074Satsuma Pharmaceuticals, Inc. (STSA)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2020-08-204Wave Life Sciences Ltd. (WVE)Grant/award (A): 10,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1657768 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs